Benzydamine EP Impurity B

Simultaneous Determination of Benzydamine Hydrochloride and Five Impurities in an Oral Collutory as a Pharmaceutical Formulation by High-Performance Liquid Chromatography
Giuseppe Carlucci*, Piera Iuliani, and Lucia Di Federico
J Chromatogr Sci. 2010 Nov;48(10):854-9
 
Photodegradation of Benzydamine: Phototoxicity of an Isolated Photoproduct on Erythrocytes
Franklin vargas', carlos rivas, ruben machado, and zaldeth sarabla
I Journal of Pharmaceutical Sciences Vol. 82, No. 4, April 1993
 
Development and validation of a stability indicating related substances of benzydamine hydrochloride and chlorhexidine gluconate by rp-hplc and its degradation
Gopinath. K, 2Dr. M. Subba Rao
Journal of Emerging Technologies and Innovative Research (JETIR) October 2018, Volume 5, Issue 10
 
Development and Validation of RP-HPLC and Ultraviolet Spectrophotometric Methods of Analysis for the Quantitative Determination of Chlorhexidine Gluconate and Benzydamine Hydrochloride in Pharmaceutical Dosage Forms
Aysegul Dogan* and Nursabah E. Bascı
Current Pharmaceutical Analysis, 2011, 7, 167-175

Benzydamine EP Impurity B is chemically 3-(1,5-Dibenzyl-1H-indazol-3-yloxy)-N,N-dimethylpropan-1-amine hydrochloride. Benzydamine EP Impurity B is supplied with detailed characterization data compliant with regulatory guideline. Benzydamine EP Impurity B can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Benzydamine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.